StockData
CareDx, Inc. logo

CareDx, Inc. (CDNA) stock

CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3024% above fair value
$74.56+0.84 (+1.14%)

Close on Nov 17, 2026Market cap $3.92BP/E 31.2Yield –

CareDx pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

CareDx's pe ratio was 39.2× on Nov 11, 2026, against 15.2× a year earlier. Over the last 2 years it ranged from 11.0× to 381.7×, with a median of 24.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202639.2×+25.5
2025Dec 31, 202513.7×−95.3
2015Jul 31, 2015109.0×−272.7
2014Dec 31, 2014381.7×–

More CareDx figures

See a number that looks wrong?